Skip to main content
RECCE PHARMACEUTICALS LTD logo

RECCE PHARMACEUTICALS LTD — Investor Relations & Filings

Ticker · RCE ISIN · AU000000RCE5 LEI · 549300TKQWXKEHP10T28 ASX Manufacturing
Open in API
Filings indexed 687 across all filing types
Latest filing 2020-09-29 AGM Information
Country AU Australia
Listing ASX RCE

About RECCE PHARMACEUTICALS LTD

https://www.recce.com.au

Recce Pharmaceuticals Ltd is dedicated to the development and commercialization of a new class of synthetic anti-infectives designed to address the global challenge of antimicrobial resistance. The company's lead compound, RECCE® 327, is a broad-spectrum synthetic antibiotic engineered with a unique mechanism of action to combat hyper-mutating bacteria, including both Gram-positive and Gram-negative species. This technology is specifically formulated to maintain efficacy over repeated use, targeting critical medical needs such as sepsis, burn wound infections, and urinary tract infections. By utilizing a proprietary synthetic polymer-based platform, the company aims to disrupt bacterial cellular processes in a manner that prevents the development of resistance, providing a potential solution for multi-drug resistant pathogens.

Recent filings

Filing Released Lang Actions
2020 Annual General Meeting 2 pages 324.7KB
AGM Information Classification · 95% confidence The document is an ASX announcement regarding the scheduling and details of the company's 2020 Annual General Meeting (AGM). It discusses the date of the AGM, nomination deadlines for director elections, and mentions that further details will be provided in the AGM notice. There is no financial data, no report attached or published, and the document is relatively short (2468 characters). It is clearly an announcement about the AGM rather than the AGM materials or the annual report itself. Therefore, it fits the category of AGM Information (AGM-R).
2020-09-29 English
Issue of Placement Shares 2 pages 346.8KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 30 September 2020 regarding the issue of placement shares following a capital raising. It details the allocation of shares and options to investors and mentions forthcoming Appendix 2A and 3G filings related to the securities issue. The content focuses on capital raising and share issuance activities, not on financial results, management changes, or other report types. The document length is short (2602 characters) and it is a direct announcement of share issuance following a placement. Therefore, the document fits the category of Capital/Financing Update (CAP).
2020-09-29 English
Appendix 2A 15 pages 292.5KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes details about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. This type of document is a formal announcement related to capital raising or securities issuance, specifically the application for quotation of new securities. It is not a financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) because it relates to the issuance and quotation of securities as part of a financing transaction.
2020-09-29 English
Appendix 2A 15 pages 293.4KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the issuance and quotation of securities, specifically related to options being exercised or convertible securities being converted. This type of document is a formal announcement related to capital changes, specifically the issuance and quotation of new securities. It is not a financial report, earnings release, or management discussion. It fits the category of announcements regarding new share issues or capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief notice but a formal application form for quotation of securities.
2020-09-29 English
Cleansing Statement 1 page 252.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement titled 'Cleansing notice under section 708A of the Corporations Act'. It discusses the issuance of shares and compliance with specific sections of the Corporations Act related to disclosure exemptions. The document is short (1156 characters) and serves as a regulatory notice about share issuance without full disclosure, rather than a full financial report or detailed capital update. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-09-29 English
Appendix 3G 12 pages 275.2KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 3G form, which is a notification to the ASX (Australian Securities Exchange) regarding the issue, conversion, or payment up of equity securities. It details the issuance of unlisted options as part of fees payable to a lead manager for a placement. The document is a regulatory announcement about a capital/financing activity, specifically the issuance of securities. It is not a full financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) as it provides an update on the company's financing activities related to securities issuance.
2020-09-29 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.